What changed: Uveal melanoma
Every dated change on the records linked to Uveal melanoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Approval3Regulatory1Milestone7This record1
September 2026 · 1
2023 · 3
- 2023ApprovalMelphalan (including hepatic delivery system)Melphalan (including hepatic delivery system) approved in US
Uveal melanoma with unresectable hepatic metastases via hepatic delivery system (Hepzato Kit)
- 2023ApprovalMelphalan hepatic delivery systemMelphalan hepatic delivery system approved in US
Uveal melanoma with unresectable hepatic metastases affecting less than half the liver and no or limited extrahepatic disease
- 2023MilestonePercutaneous hepatic perfusion (chemosaturation)Percutaneous hepatic perfusion (Hepzato) approved
A milestone in how this cancer is treated.